Einstein (São Paulo) (Apr 2022)

Factors associated with the identification of drug therapy problems among older patients in Primary Health Care

  • Bianca Menezes Dias,
  • Djenane Ramalho-de-Oliveira,
  • Bruna Damazio Santos,
  • Carina de Morais Neves,
  • Grazielli Cristina Batista de Oliveira,
  • Daniela Álvares Machado Silva,
  • Yone de Almeida Nascimento,
  • Annaline Stiegert Cid,
  • Gabriela Oliveira Buzelin,
  • Sabrina Gonçalves Ferreira,
  • Kirla Barbosa Detoni,
  • Mariana Martins Gonzaga do Nascimento

DOI
https://doi.org/10.31744/einstein_journal/2022ao6544
Journal volume & issue
Vol. 20

Abstract

Read online

ABSTRACT Objective To determine the frequency of drug therapy problems among older adults in Primary Health Care, and to analyze the factors associated with their identification in the initial patient assessment, carried out by pharmacists offering medication therapy management services. Methods A cross-sectional study conducted with data from 758 older adults followed up in medication therapy management services in Primary Health Care in the cities of Belo Horizonte, Betim, and Lagoa Santa (MG, Brazil). Univariate and multivariate analyses were performed to evaluate the factors associated with identification of four or more drug therapy problems in the initial clinical assessment. Results A total of 1,683 drug therapy problems were identified, 73.6% of older patients had at least one problem. The most frequent problems were nonadherence (23.0%) and the need for additional drug therapy (18.0%). Polypharmacy, chronic obstructive pulmonary disease, hypertension, diabetes mellitus, heart failure, and aged 75 years or older remained positively and statistically associated with identification of four or more drug therapy problems (p<0.05). Conclusion There is a high frequency of problems related to medication use among older users of Primary Health Care, and the medication therapy management services should be prioritized to the older patients, who present with polypharmacy, chronic obstructive pulmonary disease, hypertension, diabetes mellitus, heart failure, and age ≥ 75 years, since they are more likely to have more drug therapy problems.

Keywords